Desmoplastic Small Round Cell Tumors: Investigation of its Pathogenesis and Development of Novel Therapies |
Memorial Sloan-Kettering Cancer Center / Andrea Ventura, MD, PhD |
Innovation Grants |
2023 |
New York |
In Situ CD19.CAR-T Generation Using TRIDENT System for Pediatric B Cell Malignancies |
Baylor College of Medicine / Masataka Suzuki, PhD |
Innovation Grants |
2023 |
Texas |
Pre-Targeted Radioimmunotherapy for Desmoplastic Small Round Cell Tumors |
Memorial Sloan-Kettering Cancer Center / Madelyn Espinosa-Cotton, PhD |
Young Investigator Grants |
2023 |
New York |
Identifying Therapeutic Vulnerabilities in Pediatric AML through Investigation of the MECOM Transcriptional Network |
Boston Children’s Hospital / Richard Voit, MD/PhD |
Young Investigator Grants |
2023 |
Massachusetts |
A Novel Adjunctive LAT-Activating CART (ALA-CART) Cell Platform for the Treatment of Acute Leukemia |
University of Colorado Denver_ Anschutz Medical Campus / Catherine Danis, PhD |
Young Investigator Grants |
2023 |
Colorado |
Creating an Infrastructure for Collaborative Clinical Research and Publication of Consensus Guidelines for RUNX1 Familial Platelet Disorder |
The Cleveland Clinic Foundation / Brittany Stewart, PhD |
RUNX1 Early Career Investigator Grants |
2023 |
Ohio |
Immunoglobulin High-Throughput Sequencing for Refining Risk Stratification in Infant B-ALL |
University of Rochester / Carol Fries Simpson, MD |
Reach Grants |
2023 |
New York |
Identification of Aberrantly Methylated Differentially Expressed Genes to Distinguish High- vs. Low-Risk Retinoblastoma |
Children’s Hospital Los Angeles / Jesse Berry, MD |
Reach Grants |
2023 |
California |
Mechanisms to Redirect Tumor Associated Macrophages to Target Retinoblastoma Cells |
The Regents of the University of Minnesota / Timothy Hallstrom, PhD |
Innovation Grants |
2023 |
Minnesota |
Targeting Chromatin Remodeling Complexes for Rhabdomyosarcoma (RMS) Therapy |
Dana-Farber Cancer Institute / Jun Qi, PhD |
Innovation Grants |
2023 |
Massachusetts |